Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, Selonabant, is a small molecule antagonist of cannabinoid binding receptor type-1. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
3
Frequently Asked Questions
What is Market Cap of Anebulo Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Anebulo Pharmaceuticals Inc market cap is $94.49M.
What is the 52-week high for Anebulo Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Anebulo Pharmaceuticals Inc 52 week high is $3.42 as of October 10, 2025.
What is the 52-week low for Anebulo Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Anebulo Pharmaceuticals Inc 52 week low is $0.8001 as of October 10, 2025.
What is Anebulo Pharmaceuticals Inc stock price today?
Anebulo Pharmaceuticals Inc stock price today is $2.33.
What was Anebulo Pharmaceuticals Inc stock price yesterday?
Anebulo Pharmaceuticals Inc stock price yesterday was $2.30.
What is the PE ratio of Anebulo Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Anebulo Pharmaceuticals Inc’s P/E ratio is -8.59.
What is the Price-to-Book ratio of Anebulo Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Anebulo Pharmaceuticals Inc P/B ratio is 8.1057.
What is the 50-day moving average of Anebulo Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Anebulo Pharmaceuticals Inc 50-day moving average is $2.47.
How many employess does Anebulo Pharmaceuticals Inc has?